NB-2111

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNB-2111

Drug Alias Namecannabinoid derivatives (Nemus/University of Mississippi)cannabinoid derivatives (Emerald Bioscience/University of Mississippi)cannabinoid derivatives (Skye Bioscience/University of Mississippi)NB-2111

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCannabinoid receptor modulators

TargetsCannabinoid receptor

Therapy Area/IndicationsPeripheral Nervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Mississippi

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Mississippi Skye Bioscience Inc

Active IndicationsN/A

Inactive IndicationsPeripheral Nervous System Diseases

Other Information

ATC CodeN/A